Variant report
Variant | nsv1029949 |
---|---|
Chromosome Location | chr6:66379911-66403840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9283820 | chr6:66379911-66379912 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs530580654 | chr6:66379912-66379913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550368246 | chr6:66379929-66379930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570921783 | chr6:66379957-66379958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539589083 | chr6:66380009-66380010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs151262889 | chr6:66380030-66380031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566782215 | chr6:66380093-66380094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34934708 | chr6:66380098-66380099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs67462586 | chr6:66380105-66380106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200612283 | chr6:66380106-66380107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376269177 | chr6:66380195-66380196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141545419 | chr6:66380253-66380254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556055200 | chr6:66380409-66380410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs180982998 | chr6:66380448-66380449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546567906 | chr6:66380508-66380509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147048304 | chr6:66380565-66380566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76472208 | chr6:66380656-66380657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147665027 | chr6:66380679-66380680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566495941 | chr6:66380686-66380687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79759497 | chr6:66380718-66380719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72884156 | chr6:66380748-66380749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532977833 | chr6:66380763-66380764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186443137 | chr6:66380803-66380804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188832387 | chr6:66380837-66380838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72884159 | chr6:66380876-66380877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181586423 | chr6:66380951-66380952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186099489 | chr6:66380981-66380982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561470777 | chr6:66381050-66381051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142306850 | chr6:66381073-66381074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140687422 | chr6:66381092-66381093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546741578 | chr6:66381097-66381098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377128817 | chr6:66381098-66381099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566965054 | chr6:66381104-66381105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150160939 | chr6:66381139-66381140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549445619 | chr6:66381172-66381173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569559048 | chr6:66381216-66381217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573459054 | chr6:66381218-66381219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558306808 | chr6:66381289-66381290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571718634 | chr6:66381296-66381297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190863825 | chr6:66381332-66381333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534421752 | chr6:66381358-66381359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552755629 | chr6:66381361-66381362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535553228 | chr6:66381395-66381396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114165991 | chr6:66381405-66381406 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565441570 | chr6:66381412-66381413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs993015 | chr6:66381427-66381428 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs138598366 | chr6:66381455-66381456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9345669 | chr6:66381472-66381473 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs184103002 | chr6:66381484-66381485 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149065293 | chr6:66381491-66381492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66379000-66381600 | Weak transcription | Hela-S3 | cervix |
2 | chr6:66381400-66382000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr6:66381600-66382200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr6:66381600-66382200 | Enhancers | Hela-S3 | cervix |
5 | chr6:66381600-66383600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr6:66390800-66391000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr6:66390800-66391200 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr6:66390800-66391800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr6:66391400-66392000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:66392800-66393800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:66393800-66396000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:66396000-66396200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:66396200-66396600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:66399600-66400400 | Enhancers | Placenta | Placenta |
15 | chr6:66401800-66402200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
16 | chr6:66402200-66403400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
17 | chr6:66403600-66403800 | Enhancers | Rectal Mucosa Donor 29 | rectum |